AI assistant
ENTROPY NEURODYNAMICS LIMITED — Capital/Financing Update 2018
Dec 13, 2018
64855_rns_2018-12-13_f4e77e3d-816c-4bb6-b212-2bafe0f18851.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [178 x 58] intentionally omitted <==
12 December 2018
Mr Dale Allen Senior Adviser, Listings Compliance (Perth) ASX Compliance Pty Ltd Level 40, Central Park 152-158 St Georges Terrace PERTH WA 6000
By Email: [email protected]
Dear Mr Allen
Exopharm Limited – Capital Structure and Restricted Securities Statement
We refer to ASX’s letter to Jackson McDonald dated 4 December 2018 pursuant to which ASX provides conditional approval for the admission of Exopharm Limited’s ( Company ) shares to official quotation on ASX ( Approval Letter ) and confirm the following:
Capital Structure
The capital structure of Exopharm Limited (ACN 163 765 991) ( Exopharm ) as at 12 December 2018 is as follows:
| Security type | Number |
|---|---|
| Shares(ordinary, fully paid) | 80,500,000 |
Restricted Securities
The number of Exopharm securities subject to ASX restrictions and the restriction period applied to those securities as at 10 December 2018 is as follows:
| Period of Restriction | Shares |
|---|---|
| 24 months from admission to the Official List of ASX | 35,661,570 |
| 12 months from issue of security | 2,963,435 |
| Unrestricted | 41,874,995 |
| Total | 80,500,000 |
Please find attached Appendix A for further details.
Yours faithfully
==> picture [85 x 48] intentionally omitted <==
David Parker Non-Executive Director and Company Secretary Exopharm Limited
EXOPHARM LIMITED ACN: 163 765 991 ASX:EX1 Address: Level 17, 31 Queen Street Melbourne 3000 Telephone: 03 9111 0026 Email: [email protected] Web: www.exopharm.com
Appendix A
ABN: 27 152 260 814
==> picture [10 x 9] intentionally omitted <==
==> picture [10 x 9] intentionally omitted <==
==> picture [10 x 9] intentionally omitted <==
==> picture [10 x 9] intentionally omitted <==
1300 288 664 (within australia) +61 2 9698 5414 (international) [email protected] www.automic.com.au
Level 5, 126 Phillip Street, Sydney NSW 2000 GPO Box 5193, Sydney NSW 2001
Issued Capital Report
EXOPHARM LIMITED
Security Class(es): EX1ESC1 - ESCROW ORDINARY SHARES 12M FROM 23/07/18 Security Class(es): EX1ESC2 - ESCROW ORDINARY SHARES 12M FROM 10/08/18 Security Class(es): EX1ESC24 - ESCROW ORDINARY SHARES 24M Security Class(es): EX1ESC3 - ESCROW ORDINARY SHARES 12M FROM 8/06/18 Security Class(es): EX1 - ORDINARY FULLY PAID SHARES
==> picture [15 x 14] intentionally omitted <==
As at Date: 11-Dec-2018
| SecurityCode | Security Name | CHESSHolders | CHESS Holdings | % CHESSHoldings | IssuerHolders | Issuer Holdings | % IssuerHoldings | Total Holders | Total Holdings |
|---|---|---|---|---|---|---|---|---|---|
| EX1 | ORDINARY FULLY PAID SHARES | 440 | 35,837,131 | 85.58% | 114 | 6,037,864 | 14.42% | 554 | 41,874,995 |
| EX1ESC1 | ESCROW ORDINARY SHARES12M FROM 23/07/18 | 0 | 0 | 0.00% | 26 | 1,719,034 | 100.00% | 26 | 1,719,034 |
| EX1ESC2 | ESCROW ORDINARY SHARES12M FROM 10/08/18 | 0 | 0 | 0.00% | 35 | 959,401 | 100.00% | 35 | 959,401 |
| EX1ESC24 | ESCROW ORDINARY SHARES24M | 0 | 0 | 0.00% | 33 | 35,661,570 | 100.00% | 33 | 35,661,570 |
| EX1ESC3 | ESCROW ORDINARY SHARES12M FROM 8/06/18 | 0 | 0 | 0.00% | 4 | 285,000 | 100.00% | 4 | 285,000 |
| TOTAL | 440 | 35,837,131 | 212 | 44,662,869 | 652 | 80,500,000 |
==> picture [10 x 10] intentionally omitted <==
Report generated on 11-Dec-2018 at 11:02 AM
Sydney Level 5 126 Phillip Street Sydney NSW 2000
Perth Level 2 267 St Georges Terrace Perth WA 6000
Melbourne Level 12 575 Bourke Street Melbourne VIC 3000